Cite

Appel, S., Chapman, J., Shoenfeld, Y. (2007). Infection and vaccination in chronic fatigue syndrome: Myth or reality? Autoimmunity, 40, 48–53.10.1080/08916930701197273Search in Google Scholar

Bansal, A. S., Bradley, A. S., Bishop, K. N., Kiani-Alikhan, S., Ford, B. (2012). Chronic fatigue syndrome, the immune system and viral infection. Brain Behav. Immun., 26, 24–31.10.1016/j.bbi.2011.06.016Open DOISearch in Google Scholar

Barah, F., Vallely, P. J., Chiswick, M. L., Cleator, G. M., Kerr, J. R. (2001). Association of human parvovirus B19 infection with acute meningoencephalitis. Lancet, 358, 729–730.10.1016/S0140-6736(01)05905-0Search in Google Scholar

Barah, F., Whiteside, S., Batista, S., Morris, J. (2014). Neurological aspects of human parvovirus B19 infection: A systematic review. Rev. Med. Virol., 24, 154–168.10.1002/rmv.1782Open DOISearch in Google Scholar

Brenu, E. W., van Driel, M. L., Staines, D. R., Ashton, K. J., Ramos, S. B., Keane, J., Klimas, N. G., Marshall-Gradisnik, S. M. (2011). Immunological abnormalities as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis. J. Transl. Med., 9, 81.10.1186/1479-5876-9-81Open DOISearch in Google Scholar

Brown, K. E., Anderson, S. M., Young, N. S. (1993). Erythrocyte P antigen: Cellular receptor for B19 parvovirus. Science, 262, 114–117.10.1126/science.8211117Search in Google Scholar

Carruthers, B. M., van de Sande, M. I., De Meirleir, K. L., Klimas, N. G., Broderick, G., Mitchell, T., Staines, D., Powles, A. C., Speight, N., Vallings, R., Bateman, L., Baumgarten-Austrheim, B., Bell, D. S., Carlo-Stella, N., Chia, J., Darragh, A., Jo, D., Lewis, D., Light, A. R., Marshall-Gradisbik, S., Mena, I., Mikovits, J. A., Miwa, K., Murovska, M., Pall, M. L., Stevens, S. (2011). Myalgic encephalomyelitis: International Consensus Criteria. J. Intern. Med., 270, 327–338.10.1111/j.1365-2796.2011.02428.xSearch in Google Scholar

Chapenko, S., Krumina, A., Kozireva, S., Nora, Z., Sultanova, A., Viksna, L., Murovska, M. (2006). Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome. J. Clin. Virol., 37 Suppl 1, S47–51.10.1016/S1386-6532(06)70011-7Open DOISearch in Google Scholar

Chapenko, S., Krumina, A., Logina, I., Rasa, S., Chistjakovs, M., Sultanova, A., Viksna, L., Murovska, M. (2012). Association of active human herpesvirus-6, -7 and parvovirus b19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Adv. Virol., 2012, 205085.10.1155/2012/205085342616322927850Search in Google Scholar

Cooling, L. L., Koerner, T. A., Naides, S. J. (1995). Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. J. Infect. Dis., 172, 1198–1205.10.1093/infdis/172.5.11987594654Search in Google Scholar

Corcoran, C., Hardie, D., Yeats, J., Smuts, H. (2010). Genetic variants of human parvovirus B19 in South Africa: Circulation of three genotypes and identification of a novel subtype of genotype 1. J. Clin. Microbiol., 48, 137–142.10.1128/JCM.00610-09Search in Google Scholar

Cossart, Y. E., Field, A. M., Cant, B., Widdows, D. (1975). Parvovirus-like particles in human sera. Lancet, 1, 72–73.10.1016/S0140-6736(75)91074-0Search in Google Scholar

Couper, K. N., Blount, D. G., Riley, E. M. (2008). IL-10: The master regulator of immunity to infection. J. Immunol., 180, 5771–5777.10.4049/jimmunol.180.9.5771Search in Google Scholar

Fremont, M., Metzger, K., Rady, H., Hulstaert, J., De Meirleir, K. (2009). Detection of herpesviruses and parvovirus B19 in gastric and intestinal mucosa of chronic fatigue syndrome patients. In Vivo, 23, 209–213.Search in Google Scholar

Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G., Komaroff, A. (1994). The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med., 121, 953–959.10.7326/0003-4819-121-12-199412150-00009Search in Google Scholar

Guindon, S., Dufayard, J. F., Lefort, V., Anisimova, M., Hordijk, W., Gascuel, O. (2010). New algorithms and methods to estimate maximum-likelihood phylogenies: Assessing the performance of PhyML 3.0. Syst. Biol., 59, 307–321.10.1093/sysbio/syq010Search in Google Scholar

Hemauer, A., Gigler, A., Searle, K., Beckenlehner, K., Raab, U., Broliden, K., Wolf, H., Enders, G., Modrow, S. (2000). Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women. J. Med. Virol., 60, 48–55.10.1002/(SICI)1096-9071(200001)60:1<48::AID-JMV9>3.0.CO;2-EOpen DOISearch in Google Scholar

Ito, K., Shimizu, N., Watanabe, K., Saito, T., Yoshioka, Y., Sakane, E., Tsunemine, H., Akasaka, H., Kodaka, T., Takahashi, T. (2013). Analysis of viral infection by multiplex polymerase chain reaction assays in patients with liver dysfunction. Intern. Med., 52, 201–211.2331884910.2169/internalmedicine.52.8206Search in Google Scholar

Johnston, S., Brenu, E. W., Staines, D., Marshall-Gradisnik, S. (2013). The prevalence of chronic fatigue syndrome/myalgic encephalomyelitis: A meta-analysis. Clin. Epidemiol., 5, 105–110.10.2147/CLEP.S3987623576883Open DOISearch in Google Scholar

Kerr, J. R. (2000). Pathogenesis of human parvovirus B19 in rheumatic disease. Ann. Rheum. Dis., 59, 672–683.10.1136/ard.59.9.672Search in Google Scholar

Kerr, J. R. (2016). The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease. J. Clin. Pathol., 69, 279–291.10.1136/jclinpath-2015-203455Search in Google Scholar

Kerr, J. R., Barah, F., Mattey, D. L., Laing, I., Hopkins, S. J., Hutchinson, I. V., Tyrrell, D. A. (2001). Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue. J. Gen. Virol., 82, 3011–3019.10.1099/0022-1317-82-12-3011Open DOISearch in Google Scholar

Kerr, J. R., Gough, J., Richards, S. C., Main, J., Enlander, D., McCreary, M., Komaroff, A. L., Chia, J. K. (2010). Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J. Gen. Virol., 91, 893–897.10.1099/vir.0.017590-0Open DOISearch in Google Scholar

Kerr, J. R., Tyrrell, D. A. (2003). Cytokines in parvovirus B19 infection as an aid to understanding chronic fatigue syndrome. Curr. Pain Headache Rep., 7, 333–341.10.1007/s11916-003-0031-3Open DOISearch in Google Scholar

Luo, Y., Qiu, J. (2015). Human parvovirus B19: A mechanistic overview of infection and DNA replication. Future Virol., 10, 155–167.10.2217/fvl.14.103Search in Google Scholar

Magalhaes Ide, M., Martins, R. V., Vianna, R. O., Moyses, N., Afonso, L. A., Oliveira, S. A., Cavalcanti, S. M. (2011). Detection of human herpesvirus 7 infection in young children presenting with exanthema subitum. Mem. Inst. Oswaldo Cruz, 106, 371–373.10.1590/S0074-02762011000300020Search in Google Scholar

Manaresi, E., Gallinella, G., Zerbini, M., Venturoli, S., Gentilomi, G., Musiani, M. (1999). IgG immune response to B19 parvovirus VP1 and VP2 linear epitopes by immunoblot assay. J. Med. Virol., 57, 174–178.10.1002/(SICI)1096-9071(199902)57:2<174::AID-JMV15>3.0.CO;2-0Open DOISearch in Google Scholar

Matano, S., Kinoshita, H., Tanigawa, K., Terahata, S., Sugimoto, T. (2003). Acute parvovirus B19 infection mimicking chronic fatigue syndrome. Intern. Med., 42, 903–905.10.2169/internalmedicine.42.903Open DOISearch in Google Scholar

Modrow, S., Dorsch, S. (2002). Antibody responses in parvovirus B19 infected patients. Pathol. Biol. (Paris), 50, 326–331.10.1016/S0369-8114(02)00302-4Search in Google Scholar

Momoeda, M., Wong, S., Kawase, M., Young, N. S., Kajigaya, S. (1994). A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity. J. Virol., 68, 8443–8446.10.1128/jvi.68.12.8443-8446.1994Search in Google Scholar

Morey, A. L., Ferguson, D. J., Fleming, K. A. (1993). Ultrastructural features of fetal erythroid precursors infected with parvovirus B19 in vitro: Evidence of cell death by apoptosis. J. Pathol., 169, 213–220.10.1002/path.1711690207Search in Google Scholar

Morinet, F., Corruble, E. (2012). Chronic fatigue syndrome and viral infections. In: Snell, C. R. (Ed.). An International Perspective on the Future of Research in Chronic Fatigue Syndrome. InTech, Croatia, pp. 1–12.10.5772/28521Search in Google Scholar

Munakata, Y., Kato, I., Saito, T., Kodera, T., Ishii, K. K., Sasaki, T. (2006). Human parvovirus B19 infection of monocytic cell line U937 and antibody-dependent enhancement. Virology, 345, 251–257.10.1016/j.virol.2005.09.040Search in Google Scholar

Nicolson, G. L. (2002). Co-infections in fibromyalgia syndrome, chronic fatigue syndrome and other chronic illnesses. Fibromyalgia Frontiers,10, 5–9; 27–28.Search in Google Scholar

Ozawa, K., Ayub, J., Hao, Y. S., Kurtzman, G., Shimada, T., Young, N. (1987). Novel transcription map for the B19 (human) pathogenic parvovirus. J. Virol., 61, 2395–2406.10.1128/jvi.61.8.2395-2406.1987Search in Google Scholar

Pfrepper, K. I., Enders, M., Motz, M. (2005). Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection. J. Vet. Med. B Infect. Dis. Vet. Public Health, 52, 362–365.10.1111/j.1439-0450.2005.00874.xOpen DOISearch in Google Scholar

Sanders, P., Korf, J. (2008). Neuroaetiology of chronic fatigue syndrome: An overview. World J. Biol. Psychiatry, 9, 165–171.10.1080/15622970701310971Open DOISearch in Google Scholar

Servant-Delmas, A., Lefrere, J. J., Morinet, F., Pillet, S. (2010). Advances in human B19 erythrovirus biology. J. Virol., 84, 9658–9665.10.1128/JVI.00684-10Open DOISearch in Google Scholar

Soderlund-Venermo, M., Hokynar, K., Nieminen, J., Rautakorpi, H., Hedman, K. (2002). Persistence of human parvovirus B19 in human tissues. Pathol. Biol. (Paris), 50, 307–316.10.1016/S0369-8114(02)00307-3Open DOISearch in Google Scholar

Soderlund, M., Brown, C. S., Spaan, W. J., Hedman, L., Hedman, K. (1995). Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J. Infect. Dis., 172, 1431–1436.10.1093/infdis/172.6.14317594699Search in Google Scholar

Takahashi, Y., Murai, C., Shibata, S., Munakata, Y., Ishii, T., Ishii, K., Saitoh, T., Sawai, T., Sugamura, K., Sasaki, T. (1998). Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc. Natl. Acad. Sci. USA, 95, 8227–8232.10.1073/pnas.95.14.8227209589653169Search in Google Scholar

Tamura, K., Stecher, G., Peterson, D., Filipski, A., Kumar, S. (2013). MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol. Biol. Evol., 30, 2725–2729.10.1093/molbev/mst197384031224132122Search in Google Scholar

von Poblotzki, A., Hemauer, A., Gigler, A., Puchhammer-Stockl, E., Heinz, F. X., Pont, J., Laczika, K., Wolf, H., Modrow, S. (1995). Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: Implications for pathogenesis. J. Infect. Dis., 172, 1356–1359.10.1093/infdis/172.5.13567594677Search in Google Scholar

Zhang, L., Gough, J., Christmas, D., Mattey, D. L., Richards, S. C., Main, J., Enlander, D., Honeybourne, D., Ayres, J. G., Nutt, D. J., Kerr, J. R. (2010). Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis. J. Clin. Pathol., 63, 156–164.10.1136/jcp.2009.072561292126219955554Open DOISearch in Google Scholar

eISSN:
1407-009X
Idioma:
Inglés
Calendario de la edición:
6 veces al año
Temas de la revista:
General Interest, Mathematics, General Mathematics